Please provide your email address to receive an email when new articles are posted on . Accelerated infliximab induction reduced odds of a colectomy at 2 years in acute ulcerative colitis. Therapeutic ...
CAR T-cell therapy was first developed as a lymphoma treatment but has recently been applied to autoimmune diseases, primarily lupus, systemic sclerosis, and myositis. Up to this point, ulcerative ...
Colitis is an inflammation of the lining of the colon. A person with colitis will typically experience abdominal pain, discomfort, and diarrhea. People with colitis may experience mild chronic pain or ...
Mirikizumab, a p19-directed antibody against interleukin-23, showed efficacy in the treatment of ulcerative colitis in a phase 2 trial. We conducted two phase 3, randomized, double-blind, ...
EEN is primarily used for Crohn's disease, but its effectiveness in ulcerative colitis is unclear, necessitating further research. A systematic review analyzed 70 studies, finding no significant ...
Your belly hurts. The diarrhea keeps coming. And you certainly don’t feel like eating. These are telltale signs of colitis. But which kind? Colitis is a term used to describe inflammation in your ...
We conducted a phase 3, multicenter, randomized, double-blind, placebo-controlled trial of ozanimod as induction and maintenance therapy in patients with moderately to severely active ulcerative ...
Stercoral colitis is an inflammatory condition in which feces collect and cause pressure to build up within the colon. It can lead to complications such as rupture without treatment. Chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results